CAS 172733-08-3 appears in our catalog under these names: Varespladib methyl, 99%, Varespladib methyl/ 99.69% (existing batch purity), Varespladib methyl (A–002), Varespladib methyl, Varespladib methyl, 99.97% ,, 99.97% ,. Offered by: AmBeed, TargetMol, GLPBio, Biosynth, Chemat. Available pack sizes: 100mg, 25mg, 1mg, 5mg, 10mg, 50mg, 500mg, 2mg.
Varespladib methyl is a methyl ester resulting from the formal condensation of the carboxy group of varespladib with methanol. It is a potential therapy for the treatment of snakebite envenomings in which toxicity depends on the action of PLA2s. It has a role as an anti-inflammatory drug, an antidote, a prodrug and an EC 3.1.1.4 (phospholipase A2) inhibitor. It is a primary carboxamide, a member of benzenes, a member of indoles, a methyl ester and an aromatic ether. It is functionally related to a varespladib.
Source: ChEBI
| Molecular formula | C22H22N2O5 |
|---|---|
| Molecular weight | 394.4 g/mol |
| IUPAC name | methyl 2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetate |
| InChIKey | VJYDOJXJUCJUHL-UHFFFAOYSA-N |
| SMILES | CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)OC)C(=O)C(=O)N |
Computed by PubChem (NCBI)